Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
Copyright © 2020. Published by Elsevier Ltd..
OBJECTIVE: To assess post-discharge persistent symptoms and health-related quality of life (HRQoL) of patients hospitalized in a COVID-19 ward unit more than 100 days after their admission.
METHODS: All eligible patients were contacted by phone by trained physicians and were asked to answer to a dedicated questionnaire. Patients managed in hospital ward without needing intensive care were compared with those who were transferred in intensive care units (ICU).
RESULTS: We included 120 patients after a mean (±SD) of 110.9 (±11.1) days following admission. The most frequently reported persistent symptoms were fatigue (55%), dyspnoea (42%), loss of memory (34%), concentration and sleep disorders (28% and 30.8%, respectively). Comparisons between ward- and ICU patients led to no statistically significant differences regarding those symptoms. In both group, EQ-5D (mobility, self-care, pain, anxiety or depression, usual activity) was altered with a slight difference in pain in the ICU group.
CONCLUSION: Most patients requiring hospitalization for COVID-19 still have persistent symptoms. While there were few differences between HRQoL between ward and ICU patients, our findings must be confirmed in larger cohorts, including more severe patients.
Errataetall: |
CommentIn: J Infect. 2021 Apr;82(4):e31-e33. - PMID 33373650 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
---|---|
Enthalten in: |
The Journal of infection - 81(2020), 6 vom: 01. Dez., Seite e4-e6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Garrigues, Eve [VerfasserIn] |
---|
Links: |
---|
Themen: |
Covid-19 |
---|
Anmerkungen: |
Date Completed 07.01.2021 Date Revised 29.04.2021 published: Print-Electronic CommentIn: J Infect. 2021 Apr;82(4):e31-e33. - PMID 33373650 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2020.08.029 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314268510 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314268510 | ||
003 | DE-627 | ||
005 | 20231225152350.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2020.08.029 |2 doi | |
028 | 5 | 2 | |a pubmed24n1047.xml |
035 | |a (DE-627)NLM314268510 | ||
035 | |a (NLM)32853602 | ||
035 | |a (PII)S0163-4453(20)30562-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Garrigues, Eve |e verfasserin |4 aut | |
245 | 1 | 0 | |a Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.01.2021 | ||
500 | |a Date Revised 29.04.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: J Infect. 2021 Apr;82(4):e31-e33. - PMID 33373650 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020. Published by Elsevier Ltd. | ||
520 | |a OBJECTIVE: To assess post-discharge persistent symptoms and health-related quality of life (HRQoL) of patients hospitalized in a COVID-19 ward unit more than 100 days after their admission | ||
520 | |a METHODS: All eligible patients were contacted by phone by trained physicians and were asked to answer to a dedicated questionnaire. Patients managed in hospital ward without needing intensive care were compared with those who were transferred in intensive care units (ICU) | ||
520 | |a RESULTS: We included 120 patients after a mean (±SD) of 110.9 (±11.1) days following admission. The most frequently reported persistent symptoms were fatigue (55%), dyspnoea (42%), loss of memory (34%), concentration and sleep disorders (28% and 30.8%, respectively). Comparisons between ward- and ICU patients led to no statistically significant differences regarding those symptoms. In both group, EQ-5D (mobility, self-care, pain, anxiety or depression, usual activity) was altered with a slight difference in pain in the ICU group | ||
520 | |a CONCLUSION: Most patients requiring hospitalization for COVID-19 still have persistent symptoms. While there were few differences between HRQoL between ward and ICU patients, our findings must be confirmed in larger cohorts, including more severe patients | ||
650 | 4 | |a Letter | |
650 | 4 | |a Covid-19 | |
650 | 4 | |a Health-related quality of life | |
650 | 4 | |a Persistent symptoms | |
700 | 1 | |a Janvier, Paul |e verfasserin |4 aut | |
700 | 1 | |a Kherabi, Yousra |e verfasserin |4 aut | |
700 | 1 | |a Le Bot, Audrey |e verfasserin |4 aut | |
700 | 1 | |a Hamon, Antoine |e verfasserin |4 aut | |
700 | 1 | |a Gouze, Hélène |e verfasserin |4 aut | |
700 | 1 | |a Doucet, Lucile |e verfasserin |4 aut | |
700 | 1 | |a Berkani, Sabryne |e verfasserin |4 aut | |
700 | 1 | |a Oliosi, Emma |e verfasserin |4 aut | |
700 | 1 | |a Mallart, Elise |e verfasserin |4 aut | |
700 | 1 | |a Corre, Félix |e verfasserin |4 aut | |
700 | 1 | |a Zarrouk, Virginie |e verfasserin |4 aut | |
700 | 1 | |a Moyer, Jean-Denis |e verfasserin |4 aut | |
700 | 1 | |a Galy, Adrien |e verfasserin |4 aut | |
700 | 1 | |a Honsel, Vasco |e verfasserin |4 aut | |
700 | 1 | |a Fantin, Bruno |e verfasserin |4 aut | |
700 | 1 | |a Nguyen, Yann |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 81(2020), 6 vom: 01. Dez., Seite e4-e6 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:81 |g year:2020 |g number:6 |g day:01 |g month:12 |g pages:e4-e6 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2020.08.029 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 81 |j 2020 |e 6 |b 01 |c 12 |h e4-e6 |